Fisher & Paykel Healthcare announced the introduction of an innovative new product, the F&P 950 Heated Humidification System.
F&P 950 system
The F&P 950 will provide respiratory support across the care continuum of invasive, non-invasive and Optiflow nasal high flow therapies. It is a high performance system that is designed to be easy to set up and use, minimise condensate and provide optimal humidification for patients.
The system consists of a heater base with new sensing technologies and consumable sets. The F&P 950 is the next generation of Fisher & Paykel Healthcare’s heated humidification systems, building on the success of the market-leading F&P 850 system.
The F&P 950 system has recently completed 50,000 hours of clinical trials, and usability data has shown meaningful results, particularly in the ease of set up for clinicians. Customer feedback has been positive with 81% rating it as better than, and 99% rating it the same as or better than, the world-leading F&P 850 system.
The F&P 950 system will initially be available in New Zealand and Australia from August, followed by Canada and Europe. It will be available in the U.S. on receipt of U.S. FDA clearance.
Fisher & Paykel Healthcare